Lazari Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Sell
1,870
-326
-15% -$112K 0.21% 83
2026
Q1
$773K Sell
2,196
-47
-2% -$16.8K 0.27% 66
2025
Q4
$734K Sell
2,243
-13
-0.6% -$4.12K 0.25% 66
2025
Q3
$637K Buy
2,256
+27
+1% +$7.83K 0.21% 73
2025
Q2
$622K Sell
2,229
-42
-2% -$11.9K 0.23% 71
2025
Q1
$708K Sell
2,271
-102
-4% -$30.1K 0.29% 55
2024
Q4
$619K Sell
2,373
-9
-0.4% -$2.67K 0.25% 66
2024
Q3
$768K Buy
2,382
+15
+0.6% +$4.91K 0.33% 54
2024
Q2
$740K Buy
2,367
+49
+2% +$14.4K 0.33% 54
2024
Q1
$659K Sell
2,318
-61
-3% -$17.8K 0.36% 47
2023
Q4
$685K Sell
2,379
-118
-5% -$32.2K 0.39% 41
2023
Q3
$671K Sell
2,497
-1,385
-36% -$346K 0.4% 41
2023
Q2
$862K Buy
+3,882
New +$901K 0.48% 38

Other funds holding AMGN

Lazari Capital Management's AMGN Position: Q2 2026 in Review

Lazari Capital Management reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $112K and leaving 1,870 shares worth $677K. The position accounts for 0.21% of the portfolio, ranked #83.

Lazari Capital Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $862K in Q2 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lazari Capital Management held 1,870 shares of Amgen worth $677K as of Q2 2026.
  • Lazari Capital Management sold 326 Amgen shares in Q2 2026, an estimated $112K.
  • Amgen made up 0.21% of Lazari Capital Management's portfolio in Q2 2026, its #83 holding.
  • Lazari Capital Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Lazari Capital Management's Amgen position peaked at $862K in Q2 2023.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.